Literature DB >> 19738023

Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.

Claire Daurel, Anne-Lise Fiant, Sylvie Brémont, Patrice Courvalin, Roland Leclercq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19738023      PMCID： PMC2772339          DOI： 10.1128/AAC.01592-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Transcriptome analysis of Listeria monocytogenes identifies three groups of genes differently regulated by PrfA.

Authors:  Eliane Milohanic; Philippe Glaser; Jean-Yves Coppée; Lionel Frangeul; Yolanda Vega; José A Vázquez-Boland; Frank Kunst; Pascale Cossart; Carmen Buchrieser
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

2.  Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report.

Authors:  Anton Y Peleg; Brian A Potoski; Rhonda Rea; Jennifer Adams; Jigme Sethi; Blair Capitano; Shahid Husain; Eun J Kwak; Sunil V Bhat; David L Paterson
Journal:  J Antimicrob Chemother       Date:  2006-11-01       Impact factor: 5.790

Review 3.  Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.

Authors:  Theodoros Kelesidis; Drosos E Karageorgopoulos; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-08-01       Impact factor: 5.790

4.  Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.

Authors:  Jason J Schafer; Debra A Goff; Kurt B Stevenson; Julie E Mangino
Journal:  Pharmacotherapy       Date:  2007-07       Impact factor: 4.705

5.  Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.

Authors:  Michael W Daly; David J Riddle; Nathan A Ledeboer; W Michael Dunne; David J Ritchie
Journal:  Pharmacotherapy       Date:  2007-07       Impact factor: 4.705

6.  MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.

Authors:  David Keeney; Alexey Ruzin; Fionnuala McAleese; Ellen Murphy; Patricia A Bradford
Journal:  J Antimicrob Chemother       Date:  2007-10-29       Impact factor: 5.790

7.  Rapid development of Acinetobacter baumannii resistance to tigecycline.

Authors:  Gail E Reid; Shellee A Grim; Christine A Aldeza; William M Janda; Nina M Clark
Journal:  Pharmacotherapy       Date:  2007-08       Impact factor: 4.705

8.  RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae.

Authors:  David Keeney; Alexey Ruzin; Patricia A Bradford
Journal:  Microb Drug Resist       Date:  2007       Impact factor: 3.431

9.  Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.

Authors:  Kara B Anthony; Neil O Fishman; Darren R Linkin; Leanne B Gasink; Paul H Edelstein; Ebbing Lautenbach
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079
  9 in total
  7 in total

1.  In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.

Authors:  Teresa Spanu; Giulia De Angelis; Michela Cipriani; Barbara Pedruzzi; Tiziana D'Inzeo; Maria Adriana Cataldo; Gabriele Sganga; Evelina Tacconelli
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Landscape of Resistance-Nodulation-Cell Division (RND)-Type Efflux Pumps in Enterobacter cloacae Complex.

Authors:  François Guérin; Claire Lallement; Christophe Isnard; Anne Dhalluin; Vincent Cattoir; Jean-Christophe Giard
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 3.  Tetracycline Antibiotics and Resistance.

Authors:  Trudy H Grossman
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

4.  Designing of a Novel Multi-Antigenic Epitope-Based Vaccine against E. hormaechei: An Intergraded Reverse Vaccinology and Immunoinformatics Approach.

Authors:  Thamer H Albekairi; Abdulrahman Alshammari; Metab Alharbi; Amal F Alshammary; Muhammad Tahir Ul Qamar; Asad Ullah; Muhammad Irfan; Sajjad Ahmad
Journal:  Vaccines (Basel)       Date:  2022-04-22

Review 5.  Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review.

Authors:  Sajad Yaghoubi; Angelina Olegovna Zekiy; Marcela Krutova; Mehrdad Gholami; Ebrahim Kouhsari; Mohammad Sholeh; Zahra Ghafouri; Farajolah Maleki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-05       Impact factor: 3.267

6.  Case report of enterobacter hormaechei in sheep with respiratory disease and death.

Authors:  Hongfei Shi; Kun Wang; Li Wang; Shiyu Sun; Bozhen Li; Lunguang Yao
Journal:  BMC Vet Res       Date:  2022-01-26       Impact factor: 2.741

7.  First report of Enterobacter hormaechei with respiratory disease in calves.

Authors:  Zhicheng Wang; Lisha Duan; Fei Liu; Yun Hu; Chaoliang Leng; Yunchao Kan; Lunguang Yao; Hongfei Shi
Journal:  BMC Vet Res       Date:  2020-01-03       Impact factor: 2.741
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.